Bill116th CongressFiled Apr 2, 2019Health
H.R. 2038
State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Apr 2, 2019)
State-Based, Market-Oriented, Prescription Drug Negotiations Act of 2019
This bill authorizes health insurance issuers to jointly negotiate the prices for prescription drugs with the manufacturers of such drugs.
What just happenedMay 15, 2019
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Who’s behind it
Rep. Meadows, Mark [R-NC-11](R-NC)Sponsor
2 cosponsors2 R
2cosponsors1committees4actions2related bills15subjects
- Introduced in HouseApr 2, 2019
- May 15, 2019Committee
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Administrative State, Regulatory Reform, and Antitrust Subcommittee - Apr 2, 2019IntroReferralH11100
Referred to the House Committee on the Judiciary.
Judiciary Committee - Apr 2, 2019IntroReferralIntro-H
Introduced in House
- Apr 2, 2019IntroReferral1000
Introduced in House